Table 3.
Characteristic | Statins users (n = 917) | Non-Statin users (n = 5278) | p-value |
---|---|---|---|
Diagnoses of type 2 diabetes | 23 (2.5%) | 212 (4.0%) | 0.025a |
Person-years of follow-up (PYFU) median follow-up (IQR), years |
12720 15.4 (8.9–18.1) | 51429 8.9 (3.8–15.5) | <0.001b |
Incidence rate of type 2 diabetes (95%CI) per 1000-PYFU | 7.1 (4.2–10.1) c | 3.5 (3.0–4.0) | 0.041d |
a by Chi-square test
b by Wilcoxon rank-sum test
c Incidence rate of statin users was calculated using only PYFU effectively spent on statin treatment while their untreated PYFU was added to PYFU of non-statin users
d by univariate Fine-Gray regression model [HR = 1.58 (95%CI: 1.02–2.46)]